 |
|
MOUNTAIN VIEW, CA, May 12, 2010 (MARKETWIRE via COMTEX) --Hansen Medical, Inc. (NASDAQ: HNSN) announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) authorizing a clinical trial to investigate use of the Sensei(R) X Robotic Catheter System and the Artisan(TM) Control Catheter for treatment of Atrial Fibrillation (AF).
|
|